CCL2 and follicular lymphoma: Investigators have demonstrated that marrow MSCs from patients with follicular lymphoma, which has a relatively high rate of marrow involvement, overexpress chemokine (C-C motif) ligand 2 (CCL2) and aid in sustaining the growth of malignant B cells.